Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1808-1817

  Liu, Li ^a   Schwartz, Barbara ^a   Tsubota, Yoshiaki ^a   Raines, Elaine ^a   Kiyokawa, Hiroaki ^b   Yonekawa, Karyn ^a   Harlan, John M ^a,c   Schnapp, Lynn M ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOCHALASIN D; GUANOSINE TRIPHOSPHATASE; INTEGRIN; LIGAND; PHORBOL ESTER; PURVALANOL A; ROSCOVITINE; SMALL INTERFERING RNA; BETA INTEGRIN; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE MIGRATION INHIBITION; LUNG INJURY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL ADHESION; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LUNG; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PNEUMONIA; T LYMPHOCYTE;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE 4; EXTRACELLULAR MATRIX; HUMANS; INTEGRIN BETA CHAINS; JURKAT CELLS; LIGANDS; LUNG; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PNEUMONIA; PROTEIN KINASE INHIBITORS; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING; T-LYMPHOCYTES;

EID: 40749103427     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1808     Document Type: Article

References (49)

1. Knockaert, M., P. Greengard, and L. Meijer. 2002. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23: 417-425.
2. Shapiro, G. I. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24: 1770-1783.
3. Besson, A., R. K. Assoian, and J. M. Roberts. 2004. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat. Rev. Cancer 4: 948-955.
4. Strock, C. J., J. I. Park, E. K. Nakakura, G. S. Bova, J. T. Isaacs, D. W. Ball, and B. D. Nelkin. 2006. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66: 7509-7515.
5. Park, D. S., E. J. Morris, J. Padmanabhan, M. L. Shelanski, H. M. Geller, and L. A. Greene. 1998. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol. 143: 457-467.
6. 1-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20: 6055-6062.
7. Steeber, D. A., G. M. Venturi, and T. F. Tedder. 2005. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol. 26: 9-12.
8. 1 integrin-dependent leukocyte adhesion. J. Biol. Chem. 277: 40893-40900.
9. 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J. Immunol. 162: 4842-4848.
10. Kato, Y., and D. Gospodarowicz. 1985. Effect of exogenous extracellular matrices on proteoglycan synthesis by cultured rabbit costal chondrocytes. J. Cell Biol. 100: 486-495.
11. Van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
12. Negash, S., H. S. Wang, C. Gao, D. Ledee, and P. Zelenka. 2002. Cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells. J. Cell Sci. 115: 2109-2117.
13. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11: 1479-1492.
14. 1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene 18: 3930-3935.
15. 1. Proc. Natl. Acad. Sci. USA 90: 9051-9055.
16. 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J. Cell Biol. 116: 499-509.
17. Kip1 activity. Mol. Cell. Biol. 19: 7011-7019.
18. Matute-Bello, G., M. M. Wurfel, J. S. Lee, D. R. Park, C. W. Frevert, D. K. Madtes, S. D. Shapiro, and T. R. Martin. 2007. Essential role of MMP-12 in Fas-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 37: 210-221.
19. Davis, G. E., and D. R. Senger. 2005. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97: 1093-1107.
20. Mittnacht, S. 1998. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8: 21-27.
21. Knockaert, M., P. Lenormand, N. Gray, P. Schultz, J. Pouyssegur, and L. Meijer. 2002. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21: 6413-6424.
22. Harbour, J. W., and D. C. Dean. 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14: 2393-2409.
23. Chandler, D. B., D. M. Hyde, and S. N. Giri. 1983. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Pathol. 112: 170-177.
24. Namgung, U., B. H. Choi, S. Park, J. U. Lee, H. S. Seo, B. C. Suh, and K. T. Kim. 2004. Activation of cyclin-dependent kinase 5 is involved in axonal regeneration. Mol. Cell. Neurosci. 25: 422-432.
25. Gao, C., S. Negash, H. T. Guo, D. Ledee, H. S. Wang, and P. Zelenka. 2002. CDK5 regulates cell adhesion and migration in corneal epithelial cells. Mol. Cancer Res. 1: 12-24.
26. 3 integrin expression up-regulates cdc2, which modulates cell migration. J. Cell Biol. 161: 817-826.
27. Cook, H. T., S. B. Khan, A. Allen, G. Bhangal, J. Smith, R. R. Lobb, and C. D. Pusey. 2002. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am. J. Pathol. 161: 1265-1272.
28. Gherardi, D., V. D'Agati, T. H. Chu, A. Barnett, A. Gianella-Borradori, I. H. Gelman, and P. J. Nelson. 2004. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J. Am. Soc. Nephrol. 15: 1212-1222.
29. Bukanov, N. O., L. A. Smith, K. W. Klinger, S. R. Ledbetter, and O. Ibraghimov-Beskrovnaya. 2006. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444: 949-952.
30. Rossi, A. G., D. A. Sawatzky, A. Walker, C. Ward, T. A. Sheldrake, N. A. Riley, A. Caldicott, M. Martinez-Losa, T. R. Walker, R. Duffin, et al. 2006. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12: 1056-1064.
31. + T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br. J. Cancer 91: 1711-1717.
32. +-/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA 102: 18538-18543.
33. Sharma, P., Y. Shen, S. Wen, S. Yamada, A. A. Jungbluth, S. Gnjatic, D. F. Bajorin, V. E. Reuter, H. Herr, L. J. Old, and E. Sato. 2007. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc. Natl. Acad. Sci. USA 104: 3967-3972.
34. Bombeli, T., B. R. Schwartz, and J. M. Harlan. 1999. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93: 3831-3838.
35. Holub, A., J. Byrnes, S. Anderson, L. Dzaidzio, N. Hogg, and A. Huttenlocher. 2003. Ligand density modulates eosinophil signaling and migration. J. Leukocyte Biol. 73: 657-664.
36. Garcia, A. J., J. Takagi, and D. Boettiger. 1998. Two-stage activation for α5β1 integrin binding to surface-adsorbed fibronectin. J. Biol. Chem. 273: 34710-34715.
37. 1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J. Biol. Chem. 273: 10988-10993.
38. 1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes. J. Immunol. 160: 4508-4517.
39. 1 and cell adhesion in hematopoietic cells. Biochem. Biophys. Res. Commun. 301: 934-940.
40. Lin, T. H., C. Rosales, K. Mondal, J. B. Bolen, S. Haskill, and R. L. Juliano. 1995. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells: a possible signaling role for the Syk tyrosine kinase. J. Biol. Chem. 270: 16189-16197.
41. McGilvray, I. D., Z. Lu, R. Bitar, A. P. Dackiw, C. J. Davreux, and O. D. Rotstein. 1997. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J. Biol. Chem. 272: 10287-10294.
42. 2 integrin-mediated adhesion to ICAM-1 in human T cells. J. Immunol. 164: 746-753.
43. Ben-Horin, S., and I. Bank. 2004. The role of very late antigen-1 in immune-mediated inflammation. Clin. Immunol. 113: 119-129.
44. 4 integrins in gut mucosal injury of graft-versus-host disease. Int. Immunol. 7: 1183-1189.
45. 1 in models of hypersensitivity and arthritis. J. Clin. Invest. 105: 721-729.
46. 2 in TNBS-induced colitis. Immunity 17: 769-780.
47. Rane, S. G., P. Dubus, R. V. Mettus, E. J. Galbreath, G. Boden, E. P. Reddy, and M. Barbacid. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22: 44-52.
48. Sherr, C. J., and J. M. Roberts. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18: 2699-2711.
49. Rodriguez-Puebla, M. L., P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti. 2002. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am. J. Pathol. 161: 405-411.